share_log

Veru Price Target Raised To $30 From $24 At Cantor Fitzgerald, Citing Sabizabulin Emergency Use Authorization Submission For Treatment Of COVID-19

Veru Price Target Raised To $30 From $24 At Cantor Fitzgerald, Citing Sabizabulin Emergency Use Authorization Submission For Treatment Of COVID-19

Veru 的目標價格從 Cantor Fitzgerald 的 24 美元上調至 30 美元,理由是薩比扎布林提交了治療 COVID-19 的緊急使用許可
Benzinga Real-time News ·  2022/08/11 12:48

Veru Price Target Raised To $30 From $24 At Cantor Fitzgerald, Citing Sabizabulin Emergency Use Authorization Submission For Treatment Of COVID-19

Veru 的目標價格從 Cantor Fitzgerald 的 24 美元上調至 30 美元,理由是薩比扎布林提交了治療 COVID-19 的緊急使用許可

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論